N,N-dimethyl-2-[(2-methylpyrazol-3-yl)-thiophen-3-ylmethoxy]ethanamine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: N,N-dimethyl-2-[(2-methylpyrazol-3-yl)-thiophen-3-ylmethoxy]ethanamine
• 化学式: C₁₃H₁₉N₃OS
• 分子量: 265.38
• InChiKey: HEFUEFHWUOGZSJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  18
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  58.5
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• Active substance combination comprising a carbinol composition and an opioid
  申请人：LABORATORIOS DEL DR. ESTEVE, S.A.

  公开号：EP1584335A2

  公开（公告）日：2005-10-12

  The present invention relates to an active substance combination comprising at least one substituted carbinol compound and at least one opioid, a medicament comprising said active substance combination, a pharmaceutical formulation comprising said active substance combination and the use of said active substance combination for the manufacture of a medicament.

  本发明涉及一种由至少一种取代的甲醇化合物和至少一种阿片类药物组成的活性物质组合、一种由所述活性物质组合组成的药物、一种由所述活性物质组合组成的药物制剂以及使用所述活性物质组合制造药物。
• Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
  申请人：Laboratorios Dr. Esteve S.A.

  公开号：EP1632227A1

  公开（公告）日：2006-03-08

  The present invention refers to the use of derivatives of aryl (or heteroaryl) azolylcarbinols of general formula (I), and their physiologically acceptable salts, as medicinal products for human and/or animal therapeutics for the treatment of the symptoms of central neuropathic pain, especially certain subtypes of central neuropathic pain, as well as treatment of the disease causing the symptoms, the prevention or the prophylaxis of the symptoms of central neuropathic pain, especially certain subtypes of central neuropathic pain, as well as the prevention or the prophylaxis of the disease causing the symptoms. The preferred compound is Cizolirtin Citrate.

  本发明是指将通式（I）的芳基（或杂芳基）唑基甲醇的衍生物及其生理上可接受的盐类作为人类和/或动物治疗的药物产品，用于治疗中枢神经病理痛的症状，尤其是某些亚型的中枢神经病理痛，以及治疗引起中枢神经病理痛症状的疾病，预防中枢神经病理痛的症状，尤其是某些亚型的中枢神经病理痛、特别是某些亚型的中枢神经病理痛，以及治疗引起症状的疾病，预防中枢神经病理痛的症状，特别是某些亚型的中枢神经病理痛，以及预防引起症状的疾病。首选化合物是枸橼酸西唑利汀。
• Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of central neuropathic pain
  申请人：Laboratorios Dr. Esteve S.A.

  公开号：EP1642577A1

  公开（公告）日：2006-04-05

  The present invention refers to the use of derivatives of aryl (or heteroaryl) azolylcarbinols of general formula (I), and their physiologically acceptable salts, as medicinal products for human and/or animal therapeutics for the treatment of the symptoms of central neuropathic pain, especially certain subtypes of central neuropathic pain, as well as treatment of the disease causing the symptoms, the prevention or the prophylaxis of the symptoms of central neuropathic pain, especially certain subtypes of central neuropathic pain, as well as the prevention or the prophylaxis of the disease causing the symptoms.

  本发明是指将通式（I）的芳基（或杂芳基）唑基甲醇的衍生物及其生理上可接受的盐类作为人类和/或动物治疗的药物产品，用于治疗中枢神经病理痛的症状，尤其是某些亚型的中枢神经病理痛，以及治疗引起中枢神经病理痛症状的疾病，预防中枢神经病理痛的症状，尤其是某些亚型的中枢神经病理痛、特别是某些亚型的中枢神经病理痛，以及治疗引起症状的疾病，预防中枢神经病理痛的症状，特别是某些亚型的中枢神经病理痛，以及预防引起症状的疾病。
• Derivatives of aryl(or heteroaryl) azolycarbinols for the treatment of fibromyalgia
  申请人：LABORATORIOS DEL DR. ESTEVE, S.A.

  公开号：EP1690537A1

  公开（公告）日：2006-08-16

  The present invention refers to the use of derivatives of aryl (or heteroaryl) azolylcarbinols of general formula (I), and their physiologically acceptable salts, as medicinal products for human and/or animal therapeutics for the treatment of the symptoms of fibromyalgia, the prevention or the prophylaxis of the symptoms of fibromyalgia, as well as the prevention or the prophylaxis of the disease causing the symptoms.

  本发明是指将通式（I）的芳基（或杂芳基）唑基甲醇的衍生物及其生理上可接受的盐类作为人类和/或动物治疗的药物产品，用于治疗纤维肌痛的症状，预防纤维肌痛的症状，以及预防引起症状的疾病。
• Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia
  申请人：LABORATORIOS DEL DR. ESTEVE, S.A.

  公开号：EP1695704A1

  公开（公告）日：2006-08-30

  The present invention refers to the use of derivatives of aryl (or heteroaryl) azolylcarbinols of general formula (I), and their physiologically acceptable salts, as medicinal products for human and/or animal therapeutics for the treatment of the symptoms of fibromyalgia, the prevention or the prophylaxis of the symptoms of fibromyalgia, as well as the prevention or the prophylaxis of the disease causing the symptoms.

  本发明是指将通式（I）的芳基（或杂芳基）唑基甲醇的衍生物及其生理上可接受的盐类作为人类和/或动物治疗的药物产品，用于治疗纤维肌痛的症状，预防纤维肌痛的症状，以及预防引起症状的疾病。